We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+9.14%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$22.8B
AUM Growth
+$2.32B
(+11%)
Cap. Flow
-$486M
Cap. Flow
% of AUM
-2.13%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
1,019
New
29
Increased
317
Reduced
427
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$47M |
| 2 |
Qiagen
QGEN
|
+$31.1M |
| 3 |
Elanco Animal Health
ELAN
|
+$29.5M |
| 4 |
Amazon
AMZN
|
+$27.9M |
| 5 |
Tesla
TSLA
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
Charter Communications
CHTR
|
+$79.7M |
| 3 |
Comcast
CMCSA
|
+$70.1M |
| 4 |
Stellantis
STLA
|
+$55.4M |
| 5 |
Union Pacific
UNP
|
+$43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.87% |
| 2 | Financials | 14.25% |
| 3 | Healthcare | 12.4% |
| 4 | Consumer Discretionary | 11.73% |
| 5 | Communication Services | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
YPF
YPF
$19.7B
| $277K | ﹤0.01% |
59,100
| – | – |
|
802
Lennar Class B
LEN.B
$19.9B
| $251K | ﹤0.01% |
3,239
-30
| -0.9% | -$2.27K |
|
803
CNA Financial
CNA
$14.9B
| $235K | ﹤0.01% |
5,169
-235
| -4% | -$11K |
|
804
Gildan
GIL
$9.49B
| $223K | ﹤0.01% |
+6,036
| New | +$211K |
|
|
DOYU
805
DouYu International Holdings
DOYU
$140M
| $207K | ﹤0.01% |
3,030
| – | – |
|
806
United Microelectronic
UMC
$42.9B
| $146K | ﹤0.01% |
15,407
| – | – |
|
807
Itaú Unibanco
ITUB
$89.8B
| $124K | ﹤0.01% |
28,407
| – | – |
|
808
Cemex
CX
$16.9B
| $106K | ﹤0.01% |
12,601
| – | – |
|
809
Banco Bradesco
BBD
$37.4B
| $83K | ﹤0.01% |
17,768
-1
| -0% | -$4 |
|
810
Aaon
AAON
$6.95B
| – | – |
-25,697
| Closed | -$1.2M |
|
811
Applied Industrial Technologies
AIT
$12.4B
| – | – |
-15,189
| Closed | -$1.39M |
|
|
AKRO
812
DELISTED
Akero Therapeutics
AKRO
| – | – |
-39,880
| Closed | -$1.16M |
|
|
ALLK
813
DELISTED
Allakos
ALLK
| – | – |
-10,699
| Closed | -$1.23M |
|
814
Alarm.com
ALRM
$2.75B
| – | – |
-14,507
| Closed | -$1.25M |
|
|
AMED
815
DELISTED
Amedisys
AMED
| – | – |
-4,346
| Closed | -$1.15M |
|
816
AppFolio
APPF
$6.62B
| – | – |
-8,660
| Closed | -$1.23M |
|
817
AptarGroup
ATR
$8.69B
| – | – |
-8,389
| Closed | -$1.19M |
|
818
AtriCure
ATRC
$2.08B
| – | – |
-19,430
| Closed | -$1.27M |
|
819
AeroVironment
AVAV
$7.19B
| – | – |
-10,621
| Closed | -$1.23M |
|
820
American States Water
AWR
$3.44B
| – | – |
-16,030
| Closed | -$1.21M |
|
821
Axsome Therapeutics
AXSM
$11.7B
| – | – |
-20,363
| Closed | -$1.15M |
|
822
Acuity Brands
AYI
$9.99B
| – | – |
-21,281
| Closed | -$3.51M |
|
|
AZEK
823
DELISTED
The AZEK Co
AZEK
| – | – |
-28,449
| Closed | -$1.2M |
|
824
Black Diamond Therapeutics
BDTX
$95.1M
| – | – |
-53,080
| Closed | -$1.29M |
|
825
Badger Meter
BMI
$3.87B
| – | – |
-12,803
| Closed | -$1.19M |
|
Similar funds
QCM
NAMI
Aviva's Q2 2021 Portfolio in Review
As of Q2 2021, Aviva held 1,019 positions worth $22.8B, up 11% from $20.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Aviva's Q2 2021 filing shows 29 new, 317 increased, 427 reduced and 158 closed positions. Its largest new stake was DoorDash: 44,570 shares worth $7.95M. The largest sale was Alibaba, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Aviva's largest Q2 2021 buy was DoorDash: 44,570 shares worth $7.95M.
- Aviva added most to Meta Platforms (Facebook) in Q2 2021, an estimated $47M increase.
- Aviva's biggest Q2 2021 reduction was Alibaba, cutting an estimated $138M.
- Aviva fully exited Kilroy Realty in Q2 2021, selling an estimated $8.36M.
- Aviva's ten largest holdings make up 23% of its $22.8B portfolio in Q2 2021.
- Aviva opened 29 new positions and closed 158 in Q2 2021.
- Aviva's portfolio value rose 11% quarter-over-quarter to $22.8B.
Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.